{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:58:32Z","timestamp":1780379912312,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jaci.2011.05.032","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T19:45:02Z","timestamp":1311363902000},"page":"1086-1092.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["IL-5 receptor \u03b1 levels in patients with marked eosinophilia or mastocytosis"],"prefix":"10.1016","volume":"128","author":[{"given":"Todd M.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Maric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhi","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Simakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paneez","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kozhich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kolbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy D.","family":"Klion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.05.032_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0092-8674(91)90040-6","article-title":"A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific \u03b1\u00a0chain and a \u03b2 chain shared with the receptor for GM-CSF","volume":"66","author":"Tavernier","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2011.05.032_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.05.032_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.05.032_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.05.032_bib5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor \u03b1 mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2010.04.005","article-title":"Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor \u03b1 antibody, in a phase I study of subjects with mild asthma","volume":"125","author":"Busse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib7","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1073\/pnas.89.15.7041","article-title":"Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor \u03b1 subunit","volume":"89","author":"Tavernier","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.05.032_bib8","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.4049\/jimmunol.169.11.6459","article-title":"Decreased expression of membrane IL-5 receptor \u03b1 on human eosinophils: II. IL-5 downmodulates its receptor via a proteinase-mediated process","volume":"169","author":"Liu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000080043","article-title":"Soluble interleukin-5 receptor alpha is increased in acute exacerbations of chronic obstructive pulmonary disease","volume":"135","author":"Rohde","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.05.032_bib11","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.4049\/jimmunol.159.8.4024","article-title":"Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor","volume":"159","author":"Monahan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V95.5.1600.005k22_1600_1607","article-title":"Interleukin 5 regulates the isoform of its own receptor \u03b1-subunit","volume":"95","author":"Tavernier","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.032_bib13","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.170.11.5359","article-title":"Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor \u03b1-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor \u03b1 expression with loss of IL-5 responsiveness, but upregulate IL-3 receptor \u03b1 expression","volume":"170","author":"Gregory","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib14","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1182\/blood.V96.6.2163","article-title":"Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils","volume":"96","author":"Gounni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.032_bib15","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.4049\/jimmunol.169.11.6452","article-title":"Decreased expression of membrane IL-5 receptor \u03b1 on human eosinophils: I. Loss of membrane IL-5 receptor \u03b1 on airway eosinophils and increased soluble IL-5 receptor \u03b1 in the airway after allergen challenge","volume":"169","author":"Liu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib16","series-title":"World Health Organization classification of tumors: Tumours of the haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.jaci.2011.05.032_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2010.031690","article-title":"Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis","volume":"96","author":"Wilson","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2011.05.032_bib18","first-page":"1477","article-title":"Simultaneous measurement of several cytokines using small volumes of biospecimens","volume":"11","author":"Hildesheim","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaci.2011.05.032_bib19","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/blood-2003-11-3850","article-title":"Familial eosinophilia: a benign disorder?","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.032_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6750-3-17","article-title":"Quantitative real time polymerase chain reaction for measurement of human interleukin-5 receptor alpha spliced isoforms mRNA","volume":"3","author":"Perez","year":"2003","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.jaci.2011.05.032_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2307\/2532694","article-title":"Adjusted p-values for simultaneous inference","volume":"48","author":"Wright","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.jaci.2011.05.032_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.032_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2466-9-34","article-title":"IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis","volume":"9","author":"Siddiqui","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2011.05.032_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1398-9995.2008.01827.x","article-title":"Interleukin-13 promoter gene polymorphism-1112C\/T is associated with the systemic form of mastocytosis","volume":"64","author":"Nedoszytko","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.05.032_bib26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1398-9995.2004.00606.x","article-title":"Human mast cells express receptors for IL-3, IL-5 and GM-CSF: a partial map of receptors on human mast cells cultured in\u00a0vitro","volume":"59","author":"Dahl","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.05.032_bib27","doi-asserted-by":"crossref","first-page":"10509","DOI":"10.1073\/pnas.180318697","article-title":"IL-4 and IL-5 prime human mast cells for different profiles of IgE-dependent cytokine production","volume":"97","author":"Ochi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.05.032_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2004-07-2838","article-title":"High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in\u00a0vitro: correlation with apoptosis and Kit expression","volume":"105","author":"Kulka","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.032_bib29","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.032_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1189\/jlb.1207828","article-title":"Separate endocytic pathways regulate IL-5 receptor internalization and signaling","volume":"84","author":"Lei","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2011.05.032_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0609.2006.00699.x","article-title":"Interleukin-5 does not influence differential transcription of transmembrane and soluble isoforms of IL-5R \u03b1 in\u00a0vivo","volume":"77","author":"Bystrom","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2011.05.032_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2008.01885.x","article-title":"Differential expression of the interleukin 5\u03b1 receptor isoforms in blood and tissue eosinophils of nasal polyp patients","volume":"64","author":"Gevaert","year":"2009","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911008578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911008578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:28:59Z","timestamp":1758788939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911008578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0091674911008578"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.05.032","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-5 receptor \u03b1 levels in patients with marked eosinophilia or mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}